Alkermes-Avadel Pharmaceuticals deal's HSR deadline set to expire Dec. 8
Alkermes and Avadel Pharmaceuticals filed paperwork with the US antitrust authorities on Nov. 7 for their $2.1 billion transaction. The waiting period under the Hart-Scott-Rodino Act is set to expire on Dec....To view the full article, register now.
Already a subscriber? Click here to view full article